E3 UBIQUITIN LIGASE (UBE3A) PROTEIN TARGETS Application WO-2023020980-A1 World Intellectual Property Organisation (WIPO) 23 Feb 2023
Methods for treating conditions caused by higher-than-normal dopaminergic activity in… Grant US-8592466-B2 United States of America 26 Nov 2013